Anti-AGL antibody (STJA0007594)

SKU:
STJA0007594

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Glycogen debranching enzyme is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: AGL
Gene ID: 178
Uniprot ID: GDE_HUMAN
Specificity: This antibody detects endogenous levels of AGL at Human
Immunogen: Synthesized peptide derived from human AGL
Post Translational Modifications The N-terminus is blocked. Ubiquitinated.
Function Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation.
Protein Name Glycogen Debranching Enzyme
Glycogen Debrancher Includes - 4-Alpha-Glucanotransferase
Oligo-1 -4-1 -4-Glucantransferase - Amylo-Alpha-1 -6-Glucosidase
Amylo-1 -6-Glucosidase
Dextrin 6-Alpha-D-Glucosidase
Database Links Reactome: R-HSA-6798695
Reactome: R-HSA-70221
Cellular Localisation Cytoplasm
Under Glycogenolytic Conditions Localizes To The Nucleus
Alternative Antibody Names Anti-Glycogen Debranching Enzyme antibody
Anti-Glycogen Debrancher Includes - 4-Alpha-Glucanotransferase antibody
Anti-Oligo-1 -4-1 -4-Glucantransferase - Amylo-Alpha-1 -6-Glucosidase antibody
Anti-Amylo-1 -6-Glucosidase antibody
Anti-Dextrin 6-Alpha-D-Glucosidase antibody
Anti-AGL antibody
Anti-GDE antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance